Guanwen Wang
Chongqing, 400030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Promoter Hypermethylation-Induced Silencing of FXYD1 Drives Breast Cancer Metastasis via DDX5-Mediated Wnt/β-Catenin Pathway Activation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 03, 2025
Frontiers and hot topics in tumor metabolic reprogramming: a bibliometric analysis from 2014 to 2023.
Journal: Frontiers in oncology
Published: February 03, 2025
Knowledge mapping of tumor microenvironment for breast cancer: a bibliometric analysis from 2014 to 2023.
Journal: Frontiers in immunology
Published: December 24, 2024
Research hotspots and trends of epigenetic therapy in oncology: a bibliometric analysis from 2004 to 2023.
Journal: Frontiers in pharmacology
Published: July 17, 2024
Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4.
Journal: Cell communication and signaling : CCS
Published: June 18, 2024
Response to "knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022: A correspondence".
Journal: Human vaccines & immunotherapeutics
Published: June 11, 2024
Senescent cells promote breast cancer cells motility by secreting GM-CSF and bFGF that activate the JNK signaling pathway.
Journal: Cell communication and signaling : CCS
Published: June 09, 2024
Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022.
Journal: Human vaccines & immunotherapeutics
Published: April 02, 2024
Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer.
Journal: Breast cancer research : BCR
Published: June 02, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026